Your Prostate MRI deserves a second look.

DeepView Imaging delivers AI-powered prostate MRI analysis for more confident treatment decisions.
FDA-cleared (US) • CE-Marked (EU) • UKCA-Certified (UK)

Why Men & Their Doctors Trust
DeepView Imaging

6
2
3
4
9
3.6
2.4
3.3
4.2
5.1
%

AI Diagnostic Accuracy

Approximately 8–25% higher than conventional MRI interpretation.
6
5
4
3
3

Regulatory Clearances

✓ FDA-Cleared (US)
✓ CE-Marked (EU)
✓ UKCA-Certified (UK)
1 in 8

Men Will Be Diagnosed

with prostate cancer, driving demand for reliable second-opinion MRI tools.
~
6
2
3
4
3
0
2
3
4
5

Minutes

from upload to analysis, delivering insights to support faster decisions.
After feeling unsure about my MRI results, I turned to DeepView Imaging for a second review. The AI analysis was clear, detailed and delivered within minutes. The 3D imaging helped me visualize the findings and discuss with my doctor. I recommend it to anyone seeking clarity and confidence in their diagnosis."
Geoff, DeepView Imaging Customer (January 22, 2026)

We Support Your Care Team

Prostate MRI decisions are often made through collaboration between you, your physicians, and your loves ones. DeepView Imaging provides an additional layer of AI-supported analysis designed to complement your doctor’s expertise, strengthening interpretation, communication, and confidence in your care plan.

25%-60%
of imaging interpretations change after a
second opinion
AI tools help
doctors see
important details more clearly on Prostate MRI

Where Are You in Your Prostate Cancer Journey?

Whether you’ve just received difficult news or you’ve been monitoring your condition for years, DeepView Imaging AI-assisted reports provide insights that can help you and your care team make more confident decisions.

I Was Recently  Diagnosed

Before moving forward with biopsy, surgery, radiation, or another treatment plan, many patients want confirmation that nothing has been missed. DeepView Imaging provides an independent, AI-enhanced second review of your MRI.
How do I get started?

If you've had an MRI of your prostate, you can request a copy from your imaging center and upload it to our system analysis by our AI software. We'll provide a report back, with color overlays within approximately 30 minutes of submission.

Do I need a Contrast MRI?

No, our AI software only requires a bpMRI (Biparametric MRI), a non-contrast MRI. However, if you have a mpMRI (Multiparametric MRI), which includes dynamic contrast-enhancement, we can analyze that as well.  

A contrast MRI (mpMRI) study contains multiple sequences, including both contrast and non-contrast sequences. The AI software simply uses the non-contrast sequences already included in the study for its analysis.

In short - we can analyze both bmMRI & mpMRI studies, as long as they're within our acquisition parameters.

I'm Monitoring My Condition

You’ve already made it through the initial diagnosis and the first decisions. Now, you’re watching carefully. Even when your scans look stable, it’s natural to wonder whether subtle changes could be developing beneath the surface. DeepView Imaging provides an AI-enhanced review of your MRI to help identify meaningful changes and support ongoing discussions with your care team.
Can this detect subtle changes over time?

Yes. DeepView Imaging's AI-assisted analysis is designed to evaluate MRI images for patterns associated with clinically significant prostate cancer, including areas that may evolve gradually. When scans are reviewed at different time points, the goal is not only to identify obvious new lesions, but to detect subtle progression that may not immediately stand out.

Will results be comparable between scans?

Yes. Reports are structured to support longitudinal review. That means each scan is analyzed using consistent criteria so you and your physician can compare findings over time in a clear and standardized way. Structured reporting reduces ambiguity and helps focus discussions on what has changed — and what has not.

Learn More

Setting the Standard in AI-Driven Prostate Imaging

AI-Powered MRI Analysis
Advanced artificial intelligence trained specifically to detect clinically significant prostate cancer.
Validated Accuracy
93.6% AUROC performance (vs ~85% typically found via MRI) for identifying prostate cancer.
Regulatory-Cleared
Three major international regulatory clearnances including: FDA (U.S.) • CE (EU) • UKCA (UK)
Rapid Turnaround
AI-generated structured diagnostic report with 3D images delivered in just about 30 minutes.
Biopsy Trained Data
AI trained on thousands of MRI scans matched with confirmed pathology results.
Secure Digital Upload
HIPPA-complaint platform for direct MRI submission and physician-ready reporting.